Canaccord Genuity Reiterates Buy Rating on Omada Health Inc (OMDA)

January 13, 2026 6:35 AM EST Send to a Friend
Canaccord Genuity analyst Richard Close reiterated a Buy rating and $28.00 price target on Omada Health Inc (NASDAQ: OMDA).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login